Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Positive opinions in Europe for Combigan

Sep. 29, 2005

Macugen recommended for approval in Europe

Sep. 19, 2005

Biovitrum advances BVT-28949 into clinical testing for glaucoma

Sep. 15, 2005

Alcon patents superoxide dismutase mimics for optic nerve and retinal damage

Sep. 15, 2005

Genentech targets Lucentis BLA filing for December

Sep. 9, 2005

Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease

Sep. 9, 2005

Recent Allergan patent reports new treatments for glaucoma

Sep. 7, 2005

Isis grants iCo license for ISIS-13650 for eye diseases

Aug. 29, 2005

Nevanac approved for pain and inflammation related to cataract surgery

Aug. 25, 2005

Akorn signs agreement for AK-1015

Aug. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...